U.S. regulators forcing PatientsLikeMe’s Chinese majority owner to sell its stake
Cambridge, Massachusetts-based PatientsLikeMe is being forced to find a new buyer for the company because of the iCarbonX divesture mandated by U.S. regulators.
China’s Qiming Venture Partners closing $650M fund, reaches $600M in healthcare investments
The Chinese venture firm has a heavy focus on technology, and has made many investments in the healthcare space. This is its fifth fund on the U.S.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
WuXi Healthcare Ventures closes a $290M fund to invest in U.S. and China life sciences startups
The cross-border investment firm now has $350 million under management. It's invested in some high profile biopharma companies - including Juno Therapeutics, Foundation Medicine and Novira Therapeutics.